Sources said a questionnaire has been prepared for the polygraph test so that the sequence of events in the gruesome killing can be ascertained.
According to a gazette notification of the draft rules published on June 5, a hospital or medical institution may import new drug for 'compassionate use for treatment of patients suffering from life threatening disease or disease causing serious permanent disability or disease requiring therapy for unmet medical need', which has not been permitted in the country, but under Phase-III clinical trial (human trial) in the country or abroad, by making an application to the Central Drug Regulator.
The researchers from King's College London in the United Kingdom also found that most systemic side effects -- meaning side effects excluding where the injection took place -- peaked within the first 24 hours following vaccination and usually lasted 1-2 days.
There were apprehensions in the SII about rival Bharat Biotech's 'indigenous' tag, opening up shortcuts for it. One senior person, who was very familiar with the sector, told me, 'The message has gone out from the very top. Somani (V G Somani -- drug controller general of India) has told me "Bharat ka karna hai".' A fascinating excerpt from Abantika Ghosh's Billions Under Lockdown: The Inside Story Of India's Fight Against COVID-19.
The jump can be attributed to increased assistance through soft loan.
The phase 3 trial findings indicate that Covaxin induces a robust antibody response with no severe vaccine-related adverse events or deaths reported among the trial participants, the authors of the study said.
The termination of the pact comes after the deal with the Brazilian government for supply of 20 million doses of the vaccine landed in controversy and attracted investigation by authorities in that country.
Covaxin is being developed by Bharat Biotech, in collaboration with the Indian Council of Medical Research - National Institute of Virology.
Harrish M Bhatia, chief executive of 94.3 MY FM, the station under the Dainik Bhaskar group, tells Gaurav Laghate regional markets hold great potential.
The Union Cabinet on Wednesday approved a proposal to extend distribution of 5 kg foodgrains per month for free under the Pradhan Mantri Garib Anna Yojana (PMGKAY) to over 80 crore ration card holders for four months till March 2022, a decision that will cost an additional Rs 53,344 crore to the exchequer.
"The phase-III trial of 'Covishield' vaccine will begin at Sassoon hospital from next week. It is likely to start on Monday. Some volunteers have already come forward for the trial. "Around 150 to 200 volunteers will be administered the vaccine candidate dose," Dean of the state-run Sassoon General Hospital Dr Muralidhar Tambe said.
A decision in this regard was taken in the Cabinet meeting chaired by Prime Minister Narendra Modi.
Security breach came days after the firm got approval to conduct trials for Covid-19 vaccine candidate Sputnik V.
The Information and Broadcasting Ministry has come out with a comprehensive document 'Compendium of important action points' detailing its action plan for 2012-17 period.
31 satellite TV channels are awaiting the government's approval.
The government's subsidies on food, fertilisers and petroleum are estimated to decline by 39 per cent to Rs 4,33,108 crore this fiscal and fall further by 27 per cent to nearly Rs 3.18 lakh crore in 2022-23. In its revised Budget (RE) estimate for the 2021-22 fiscal, the government has pegged total subsidies to be at Rs 4,33,108 crore against the actual Budget estimate of Rs 7,07,707 crore in the previous financial year. Out of which, the food subsidy is estimated to decline to Rs 2,86,469 crore in the current fiscal from Rs 5,41,330 crore in 2020-21, while petroleum subsidy is estimated to fall to Rs 6,517 crore from Rs 38,455 crore in the said period.
A team at Bristol University used recently developed techniques to validate that the vaccine accurately follows the genetic instructions programmed into it by the Oxford University team.
The Drug Controller General of India has sent a letter to the Glenmark seeking clarifications on pricing as well as claims of therapeutic efficacy. While Glenmark has claimed this drug is effective in comorbid conditions like diabetes, hypertension, according to protocol summary (of clinical trials) the trial was not designed to access the Fabiflu in comorbid conditions.
Hyderabad-based vaccine manufacturer Bharat Biotech, which is carrying out its phase 3 trial will publish the data in July following that the company will be applying for the full licensure of Covaxin.
Home to several Yadav family bastions, Phase III of the Uttar Pradesh Assembly Elections is especially crucial for the Samajwadi Party.
The chief minister raised these issues when Modi called him up to discuss the state's COVID-19 situation and the measures being taken to tackle the crisis, according to an official statement issued here.
A day before the end of the fourth phase of lockdown, the home ministry on Saturday issued new guidelines for the phased reopening of all activities outside containment zones till June 30.
According to the report, 32 (73 per cent) out of 44 candidates analysed from the Rashtriya Janata Dal have declared criminal cases against themselves and 22 (50 per cent) of them have declared serious criminal cases against themselves in their affidavits.
The Centre on Tuesday placed orders for 44 crore doses of Covishield and Covaxin, a day after Prime Minister Narendra Modi announced that the Centre would take over the state procurement quota and provide free jabs to state governments for inoculation of all above the age of 18.
The parties intend to start the production of Sputnik V in the beginning of 2021, it added. Currently, Phase III clinical trials are approved and are ongoing in Belarus, the United Arab Emirates, Venezuela and other countries, as well as Phase II-III in India, RDIF said.
Venus Remedies has obtained permission from the Drug Controller General of India for conducting Phase III clinical trials of the new formulation developed by its research and development wing.
MMRC Managing Director Ashwini Bhide, in a series of tweets, said the activists should accept their defeat in the court "honorably".
As per RDIF, Sputnik V has a number of key advantages, including that there are no strong allergies caused by Sputnik V.
However, Cipla was very clear it does not want to get into vaccine manufacturing.
On Tuesday, the state-run Mumbai Metropolitan Region Development Authority, the planning body, indicated that it expected to award the contract before December, which would pave the way to kick start construction in the same month.
The Russian Direct Investment Fund (RDIF) and Dr Reddy's Laboratories have agreed to cooperate on clinical trials and distribution of Sputnik V vaccine in India, RDIF and Dr Reddy's said in a joint statement.
The vaccine maker Bharat Biotech said in a statement that preliminary reviews indicated that the death was unrelated to Covaxin.
Many companies globally are working on plasma research to develop and manufacture hyperimmune globulin therapies from plasma donations.
These trains would be able to accommodate as many as 240 commuters.
The establishment of these medical colleges will add at least 15,700 MBBS seats in the country.
Digital Radio collectively runs 45 radio stations across the country.
The urgent need to address a large number of beneficiaries waiting for second dose of vaccine was stressed in a meeting held by Union Health Secretary Rajesh Bhushan and Dr R S Sharma, the Chairman of Empowered Group on Technology and Data Management to Combat COVID-19, with state officials to review the status of COVID-19 vaccination on Tuesday.
The modalities of COVID-19 vaccine delivery, distribution and administration were discussed during the meeting.
Unwilling to wait till Delhi Metro's Phase-III is completed, the Centre wants construction work on "some sections" of the Phase-IV project to start immediately once the detailed project report is completed.
Modi tweeted that the meeting discussed important issues related to the progress of vaccine development, regulatory approvals and procurement.
© 2026 Rediff.com - Advertise with us - Disclaimer - Privacy Policy - Sitemap - Feedback - About us - Terms of use - Grievances